143 related articles for article (PubMed ID: 38094394)
1. Retracted: Development of a Bile Acid-Related Gene Signature for Predicting Survival in Patients with Hepatocellular Carcinoma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9865740. PubMed ID: 38094394
[TBL] [Abstract][Full Text] [Related]
2. Retracted: Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9851737. PubMed ID: 38549990
[TBL] [Abstract][Full Text] [Related]
3. Retracted: New Pyroptosis-Associated Gene Signature for Overall Survival Forecast among Patients Suffering from Hepatocellular Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9809725. PubMed ID: 37621615
[TBL] [Abstract][Full Text] [Related]
4. Retracted: Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor.
Oncology JO
J Oncol; 2023; 2023():9803262. PubMed ID: 37869587
[TBL] [Abstract][Full Text] [Related]
5. Retracted: Prediction of Hepatocellular Carcinoma Prognosis and Immune Cell Infiltration Using Gene Signature Associated with Inflammatory Response.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9759467. PubMed ID: 38094384
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9795318. PubMed ID: 37565171
[TBL] [Abstract][Full Text] [Related]
7. Retracted: A Ferroptosis-Related Gene Signature for Predicting Survival and Immunotherapy Effect in Renal Cancer.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9835478. PubMed ID: 37503419
[TBL] [Abstract][Full Text] [Related]
8. Retracted: Analysis of the Performance of Gadoxetic Acid Disodium MRI in Predicting Microvascular Invasion of Hepatocellular Carcinoma.
Imaging CMM
Contrast Media Mol Imaging; 2023; 2023():9761084. PubMed ID: 38124719
[TBL] [Abstract][Full Text] [Related]
9. Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9806284. PubMed ID: 37565158
[TBL] [Abstract][Full Text] [Related]
10. Retracted: A Novel Immune-Associated Gene Signature for Overall Survival Prediction in Patients with Oral Squamous Cell Carcinoma.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9875478. PubMed ID: 38125198
[TBL] [Abstract][Full Text] [Related]
11. Retracted: Clinical Value of PPM1G Gene in Survival Prognosis and Immune Infiltration of Hepatocellular Carcinoma.
And Biomechanics AB
Appl Bionics Biomech; 2023; 2023():9862929. PubMed ID: 37946818
[TBL] [Abstract][Full Text] [Related]
12. Retracted: Value of Serum Glycocholic Acid and Total Bile Acids in Predicting Maternal and Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy.
Healthcare Engineering JO
J Healthc Eng; 2022; 2022():9865057. PubMed ID: 36457591
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme.
International BR
Biomed Res Int; 2024; 2024():9756795. PubMed ID: 38550039
[TBL] [Abstract][Full Text] [Related]
14. Retracted: The Relationship between Ultrasonographic Features of Hepatocellular Carcinoma and the Severity of Hepatocellular Carcinoma and the Expression of PTEN and Tg737.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9848563. PubMed ID: 37829384
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Novel Epithelial-to-mesenchymal-related Gene Signature in Predicting Survival of Patients with Hepatocellular Carcinoma.
Xiao S; Hu J; Hu N; Sheng L; Rao H; Zheng G
Comb Chem High Throughput Screen; 2022; 25(8):1254-1270. PubMed ID: 33655854
[TBL] [Abstract][Full Text] [Related]
16. Retracted: Value of a Signature of Immune-Related Genes in Predicting the Prognosis of Melanoma and Its Responses to Immune Checkpoint Blocker Therapies.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9781954. PubMed ID: 37416155
[TBL] [Abstract][Full Text] [Related]
17. Retracted: Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments.
International BR
Biomed Res Int; 2023; 2023():9827803. PubMed ID: 37475816
[TBL] [Abstract][Full Text] [Related]
18. Retracted: Preliminary Evaluation of Artificial Intelligence-Based Anti-Hepatocellular Carcinoma Molecular Target Study in Hepatocellular Carcinoma Diagnosis Research.
International BR
Biomed Res Int; 2023; 2023():9850584. PubMed ID: 37475788
[TBL] [Abstract][Full Text] [Related]
19. Retracted: Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature.
International BR
Biomed Res Int; 2024; 2024():9850107. PubMed ID: 38550181
[TBL] [Abstract][Full Text] [Related]
20. Retracted: Recurrence of Early Hepatocellular Carcinoma after Surgery May Be Related to Intestinal Oxidative Stress and the Development of a Predictive Model.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9790735. PubMed ID: 37810565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
